Alnylam Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Amgen USD 2.6B 507M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Incyte USD 78.77M 10.96M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Novartis USD 3.31B 73M 2024-12
PTC Therapeutics USD 12.86M 3.42M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Takeda JPY 384.68B 2.6B 2025-06
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Xencor 10.71M 4.56M 2024-09


Alnylam Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.